STOCKHOLDERS PAVE THE WAY FOR BAYER SCHERING PHARMA

The Bayer Group has taken a further important step toward the planned integration of Schering. On Wednesday the Schering stockholders consented to the domination and profit and loss transfer agreement with Bayer subsidiary Dritte BV GmbH at an Extraordinary Stockholders' Meeting. Said Bayer Management Board Chairman Werner Wenning: "Now the condition has been fulfilled for integrating Schering as quickly as possible." The stockholders also resolved on the name change from Schering AG to "Bayer Schering Pharma Aktiengesellschaft" and elected new stockholders' representatives to the Supervisory Board. Yahoo Finance (http://biz.yahoo.com/prnews/060914/ukth011.html?.v=71)